Department of Pathology, Microbiology and Immunology, School of Medicine, University of South Carolina School of Medicine, Columbia, SC, United States.
Front Immunol. 2024 Mar 15;15:1355315. doi: 10.3389/fimmu.2024.1355315. eCollection 2024.
Macrophage activation syndrome (MAS) is a life-threatening complication of systemic juvenile arthritis, accompanied by cytokine storm and hemophagocytosis. In addition, COVID-19-related hyperinflammation shares clinical features of MAS. Mechanisms that activate macrophages in MAS remain unclear. Here, we identify the role of miRNA in increased phagocytosis and interleukin-12 (IL-12) production by macrophages in a murine model of MAS. MAS significantly increased F4/80+ macrophages and phagocytosis in the mouse liver. Gene expression profile revealed the induction of Fcγ receptor-mediated phagocytosis (FGRP) and IL-12 production in the liver. Phagocytosis pathways such as High-affinity IgE receptor is known as Fc epsilon RI -signaling and pattern recognition receptors involved in the recognition of bacteria and viruses and phagosome formation were also significantly upregulated. In MAS, miR-136-5p and miR-501-3p targeted and caused increased expression of Fcgr3, Fcgr4, and Fcgr1 genes in FGRP pathway and consequent increase in phagocytosis by macrophages, whereas miR-129-1-3p and miR-150-3p targeted and induced Il-12. Transcriptome analysis of patients with MAS revealed the upregulation of FGRP and FCGR gene expression. A target analysis of gene expression data from a patient with MAS discovered that miR-136-5p targets and , the human orthologs of mouse Fcgr3 and Fcgr4, and miR-501-3p targets , the human ortholog of mouse Fcgr1. Together, we demonstrate the novel role of miRNAs during MAS pathogenesis, thereby suggesting miRNA mimic-based therapy to control the hyperactivation of macrophages in patients with MAS as well as use overexpression of FCGR genes as a marker for MAS classification.
巨噬细胞活化综合征(MAS)是一种危及生命的全身幼年特发性关节炎并发症,伴有细胞因子风暴和噬血细胞现象。此外,COVID-19 相关的过度炎症与 MAS 具有相似的临床特征。导致 MAS 中巨噬细胞活化的机制尚不清楚。在这里,我们在 MAS 小鼠模型中鉴定了 miRNA 在增加巨噬细胞吞噬作用和白细胞介素-12(IL-12)产生中的作用。MAS 显著增加了小鼠肝脏中 F4/80+巨噬细胞和吞噬作用。基因表达谱显示肝脏中诱导了 Fcγ 受体介导的吞噬作用(FGRP)和 IL-12 的产生。吞噬作用途径,如高亲和力 IgE 受体称为 FcεRI-信号,以及涉及识别细菌和病毒和吞噬体形成的模式识别受体,也显著上调。在 MAS 中,miR-136-5p 和 miR-501-3p 靶向并导致 FGRP 途径中的 Fcgr3、Fcgr4 和 Fcgr1 基因表达增加,从而导致巨噬细胞吞噬作用增加,而 miR-129-1-3p 和 miR-150-3p 靶向并诱导 Il-12。MAS 患者的转录组分析显示 FGRP 和 FCGR 基因表达上调。对 MAS 患者的基因表达数据进行的靶向分析发现,miR-136-5p 靶向和 ,它们是小鼠 Fcgr3 和 Fcgr4 的人类同源物,而 miR-501-3p 靶向,它是小鼠 Fcgr1 的人类同源物。综上所述,我们证明了 miRNA 在 MAS 发病机制中的新作用,从而提示 miRNA 模拟物治疗可以控制 MAS 患者巨噬细胞的过度激活,并将 FCGR 基因的过表达作为 MAS 分类的标志物。